Michelle E. Melisko, MD

Treating High-Risk, Early-Stage HR+/HER2- Breast Cancer

Publish date: April 29, 2022

Dr Michelle Melisko discusses treatment for high-risk, early-stage HR+/HER2- breast cancer, i...